A Novel Patient-Derived Conceptual Model of the Impact of Celiac Disease in Adults: Implications for Patient-Reported Outcome and Health-Related Quality-of-Life Instrument Developm... von Leffler, Daniel A., MD, Acaster, Sarah, PSc, MSc, Gallop, Katy, MSc, Dennis, Melinda, RD, MS, Kelly, Ciarán P., MD, Adelman, Daniel C., MD

Volltext

Glutenase ALV003 Attenuates Gluten-Induced Mucosal Injury in Patients With Celiac Disease von Lähdeaho, Marja-Leena, Kaukinen, Katri, Laurila, Kaija, Vuotikka, Pekka, Koivurova, Olli-Pekka, Kärjä-Lahdensuu, Tiina, Marcantonio, Annette, Adelman, Daniel C, Mäki, Markku

Volltext

Outcome of 583 Entry Double-Blind Placebo-Controlled Peanut Challenges during Screening for the Palisade Phase 3 Oral Immunotherapy Trial von Vickery, Brian P., Dr, Beyer, Kirsten, Prof, Burks, A. Wesley, Dr, Casale, Thomas B., Dr, Hourihane, Jonathan O., Prof, Jones, Stacie M., Dr, Radwan, Amr, Dr, Vereda, Andrea, Dr, Adelman, Daniel C., Dr

Volltext

Assessing Quality of Life in Patients with Common Variable Immunodeficiency: Why It Matters von Adelman, Daniel C., MD, Howard, Kellee, MA, MSc

Volltext

Open‐label follow‐on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy von Fernandez‐Rivas, Montserrat, Vereda, Andrea, Vickery, Brian P., Sharma, Vibha, Nilsson, Caroline, Muraro, Antonella, Hourihane, Jonathan O'B., DunnGalvin, Audrey, Toit, George, Blumchen, Katharina, Beyer, Kirsten, Smith, Alex, Ryan, Robert, Adelman, Daniel C., Jones, Stacie M.

Volltext

Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy von Chinthrajah, R. Sharon, Jones, Stacie M., Kim, Edwin H., Sicherer, Scott H., Shreffler, Wayne, Lanser, Bruce J., Atri, Negin, Babineau, Denise C., Adelman, Daniel C., Iqbal, Ahmar, Limb, Susan L., Rudman Spergel, Amanda K., Togias, Alkis, Wood, Robert A.

Volltext

Voreloxin, a First-in-Class Anticancer Quinolone Derivative, in Relapsed/Refractory Solid Tumors: A Report on Two Dosing Schedules von ADVANI, Ranjana H, HURWITZ, Herbert I, FOX, Judith A, ALLEN, Roberta S, ADELMAN, Daniel C, GORDON, Michael S, EBBINGHAUS, Scot W, MENDELSON, David S, WAKELEE, Heather A, HOCH, Ute, SILVERMAN, Jeffrey A, HAVRILLA, Nancy A, BERMAN, Craig J

Volltext

At-home Dosing Adherence During Characterized Oral Desensitization Immunotherapy (CODIT) for Peanut Allergy von Jones, Stacie M, Vickery, Brian P., MD, FAAAAI, Bird, J. Andrew, MD, FAAAAI, Spergel, Jonathan M., MD, PhD, FAAAAI, Rachid, Rima A., MD, FAAAAI, Assa'ad, Amal H., MD,, FAAAAI, Wang, Julie, MD, Leonard, Stephanie A., MD, Laubach, Susan Stefanac, MD, FAAAAI, Kim, Edwin, MD, Davis, Benjamin P., MD, PhD, Welch, Michael, MD, FAAAAI, Heimall, Jennifer, MD, Cianferoni, Antonella, MD, PhD, FAAAAI, MacGinnitie, Andrew J., MD, PhD, FAAAAI, Crestani, Elena, MD, MS, Radwan, Amr, MBBChir, FFPM, Vereda, Andrea, MD, PhD, Adelman, Daniel C., MD, FAAAAI, Burks, A. Wesley, MD

Volltext

Using data from food challenges to inform management of consumers with food allergy: A systematic review with individual participant data meta-analysis von Patel, Nandinee, Adelman, Daniel C., Anagnostou, Katherine, Baumert, Joseph L., Blom, W. Marty, Campbell, Dianne E., Chinthrajah, R. Sharon, Mills, E.N. Clare, Javed, Bushra, Purington, Natasha, Remington, Benjamin C., Sampson, Hugh A., Smith, Alexander D., Yarham, Ross A.R., Turner, Paul J.

Volltext

Oral desensitization therapy for peanut allergy induces dynamic changes in peanut‐specific immune responses von Bajzik, Veronique, DeBerg, Hannah A., Garabatos, Nahir, Rust, Blake J., Obrien, Kimberly K., Nguyen, Quynh‐Anh, O’Rourke, Colin, Smith, Alex, Walker, Alex H., Quinn, Charlie, Gersuk, Vivian H., Farrington, Mary, Jeong, David, Vickery, Brian P., Adelman, Daniel C., Wambre, Erik

Volltext

No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease von Murray, Joseph A, Kelly, Ciarán P, Green, Peter H.R, Marcantonio, Annette, Wu, Tsung-Teh, Mäki, Markku, Adelman, Daniel C

Volltext

Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial von O'B Hourihane, Jonathan, Beyer, Kirsten, Abbas, Allyah, Fernández-Rivas, Montserrat, Turner, Paul J, Blumchen, Katharina, Nilsson, Caroline, Ibáñez, Maria D, Deschildre, Antoine, Muraro, Antonella, Sharma, Vibha, Erlewyn-Lajeunesse, Michel, Zubeldia, José Manuel, De Blay, Frederic, Sauvage, Christine D, Byrne, Aideen, Chapman, John, Boralevi, Franck, DunnGalvin, Audrey, O'Neill, Charmaine, Norval, David, Vereda, Andrea, Skeel, Ben, Adelman, Daniel C, du Toit, George

Volltext

Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapy von Calise, Justine, DeBerg, Hannah, Garabatos, Nahir, Khosa, Sugandhika, Bajzik, Veronique, Calderon, Lorena Botero, Aldridge, Kelly, Rosasco, Mario, Ferslew, Brian C., Zhu, Tong, Smulders, Ronald, Wheatley, Lisa M., Laidlaw, Tanya M., Qin, Tielin, Chichili, Gurunadh R., Adelman, Daniel C., Farrington, Mary, Robinson, David, Jeong, David, Jones, Stacie M., Sanda, Srinath, Larson, David, Kwok, William W., Baloh, Carolyn, Nepom, Gerald T., Wambre, Erik, Kim, Edwin H., Nadeau, Kari C., Nowak-Wegrzyn, Anna, Wood, Robert A., Sampson, Hugh A., Scurlock, Amy M., Chinthrajah, Sharon, Wang, Julie, Pesek, Robert D., Sindher, Sayantani B., Kulis, Mike, Johnson, Jacqueline, Spain, Katharine, Babineau, Denise C., Chin, Hyunsook, Laurienzo-Panza, Joy, Rachel Yan, Larson, David, Tielin Qin, Whitehouse, Don, Sever, Michelle L., Sanda, Srinath, Plaut, Marshall, Wheatley, Lisa M., Wesley Burks, A., Marchesini, Gina, Gilroy, Kavitha, Posso, Sylvia, Skiba, Sabrina, Nguyen, Thien-Son, Wojno, Adam, Nguyen, Tuan, Gersuk, Vivian, Nguyen, Quynh-Anh, Garber, Jessica, O’Brien, Kimberly, Larson, Brandon, Cousens-Jacobs, C., Hu, Alex

Volltext

Estimating the Probability of Tolerating Each Challenge Dose of Peanut Protein at Exit Double-Blind, Placebo-Controlled Food Challenge: Results from a Phase 3, Randomized, Double-B... von Carr, Warner, Vickery, Brian P., Zawadzki, Rezi, Griffin, Noelle M., Adelman, Daniel C., Kim, Edwin

Volltext

Safety, Tolerability, and Activity of ALV003: Results from Two Phase 1 Single, Escalating-Dose Clinical Trials von Siegel, Matthew, Garber, Mitchell E., Spencer, Andrew G., Botwick, Wendy, Kumar, Pawan, Williams, Robert N., Kozuka, Kenji, Shreeniwas, Revati, Pratha, Vijaya, Adelman, Daniel C.

Volltext

Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials von Ciaccio, Christina, Goldsobel, Alan B., Anagnostou, Aikaterini, Beyer, Kirsten, Casale, Thomas B., Deschildre, Antoine, Fernández-Rivas, Montserrat, Hourihane, Jonathan O'B., Krawiec, Marta, Lieberman, Jay, Scurlock, Amy M., Vickery, Brian P., Smith, Alex, Tilles, Stephen A., Adelman, Daniel C., Brown, Kari R., Assa'ad, Amal H., Bernstein, David I., Bird, J. Andrew, Carr, Tara F., Carr, Warner W., Cheema, Amarjit S., Corren, Jonathan, Darter, Amy Liebl, Dorsey, Morna J., Fineman, Stanley M., Fleischer, David M., Fritz, Stephen B., Gogate, Shaila U., Greiner, Alexander N., Hampel, Frank C., Jacobs, Joshua S., Jain, Sanjeev, Jarvinen-Seppo, Kirsi, Jeong, David K., Johnston, Douglas T., Kachru, Rita, Kim, Edwin H., Koleilat, Majed, Lanser, Bruce J., Leonard, Stephanie A., Maier, Mary C., Manning, Michael E., Mansfield, Lyndon E., Matz, Jonathan, Nadeau, Kari, Ohayon, Jason A., Perez, Elena, Petroni, Daniel H., Pollard, Stephen J., Ponda, Punita, Portnoy, Jay M., Rachid, Rima, Ratner, Paul H., Robison, Rachel, Rupp, Ned T., Sanders, Georgiana M., Sharma, Hemant P., Sher, Ellen R., Sher, Lawrence D., Sher, Mandel, Shreffler, Wayne G., Siri, Dareen D., Skolnick, Helen S., Soong, Weily, Soteres, Daniel F., Spergel, Jonathan M., Stillerman, Allan, Sussman, Gordon L., Tam, Jonathan, Varshney, Pooja, Waserman, Susan, Windom, Hugh H., Wood, Robert, Yang, William H.

Volltext

Longer-Term Safety and Efficacy Measures of AR101 Oral Immunotherapy for Peanut Allergy: Results from a Phase 3 Follow-On Study von Carr, Tara F., Shreffler, Wayne G., Griffin, Noelle M., Rosén, Karin, Zawadzki, Rezi, Matthews, John, Adelman, Daniel C., Jones, Stacie M.

Volltext

Onset of eosinophilic esophagitis during a clinical trial program of oral immunotherapy for peanut allergy von Nilsson, Caroline, Scurlock, Amy M., Dellon, Evan S., Brostoff, Joshua M., Pham, Trinh, Ryan, Robert, Brown, Kari R., Adelman, Daniel C., Aceves, Seema S.

Volltext

A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with... von Heath, Elisabeth I., Bible, Keith, Martell, Robert E., Adelman, Daniel C., LoRusso, Patricia M.

Volltext

Factors Associated with Villus Atrophy in Symptomatic Celiac Disease Patients on a Gluten-Free Diet von Mahadev, SriHari, Murray, Joseph A, Wu, Tsung-Teh, Kelly, Ciaran P, Maki, Markku, Green, Peter H.R, Adelman, Daniel C, Lebwohl, Benjamin

Volltext